The Interview World

India's pharmaceutical industry stands at a defining moment. While the country supplies over 20% of the world's generic medicines and more than half of UNICEF's vaccine requirements, the next phase of growth will depend on innovation, quality excellence, and global trust.

In an exclusive interview with The Interview World during the Assocham Pharma Summit & Awards 2026, Vivekanand Mishra, Co-founder and CEO of The Health Convo, shares valuable insights from the "Outlook on the Indian Pharmaceutical Sector" report.

He discusses India's journey from a manufacturing powerhouse to an innovation-driven ecosystem, the impact of the PLI scheme, the need for quality-linked incentives, the role of AI in accelerating drug discovery and supply chain efficiency, and the importance of academia-industry collaboration in fostering pharmaceutical innovation.

A compelling conversation on the opportunities, challenges, and strategic priorities that will shape India's pharmaceutical future.

U.S. Food and Drug Administration

India’s Pharmaceutical Edge Lies Beyond Affordability Vivekanand Mishra, Co-founder & CEO, The Health Convo discusses India's pharmaceutical outlook, PLI impact, policy shifts, counterfeit drugs, and innovation through academia-industry collaboration